Home> Products> clinical studies

{ "products": [ { "_id": "666be1f505b00e1ad41ca281", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "RISPERIDIN 4 ", "description": "RISPERIDIN 4 \nRisperidone (4mg)\nIntroduction:\n\nRisperidin 4 contains Risperidone at a 4mg dosage, an effective second-generation antipsychotic used to manage various psychiatric disorders. This medication is renowned for its ability to treat conditions such as schizophrenia, bipolar disorder, and certain behavioral disturbances, offering significant improvements in patients' quality of life.\nKey Features and Benefits:\n\nAntipsychotic Efficacy:\n\nRisperidin 4 works by antagonizing dopamine and serotonin receptors in the brain, which helps reduce psychotic symptoms like hallucinations, delusions, and disorganized thinking commonly associated with schizophrenia.\nMood Stabilization:\n\nIn bipolar disorder, Risperidin 4 plays a crucial role in stabilizing mood swings. It effectively reduces the severity and frequency of manic episodes and helps prevent depressive relapses, promoting emotional stability.\nBehavioral Improvement:\n\nFor individuals with behavioral disturbances, such as those seen in autism spectrum disorders or dementia, Risperidin 4 helps mitigate aggression, agitation, and irritability, thereby improving social interactions and overall behavior.\nCognitive Function:\n\nSome studies suggest that Risperidin 4 can enhance cognitive functions in certain patients, improving aspects like attention, executive function, and overall cognitive performance.\nDosage and Administration:\n\nInitial Dosage:\nThe starting dose of Risperidin 4 is typically 4mg once daily, taken orally with or without food. Dosage adjustments should be based on individual clinical response and tolerability.\nTitration and Maintenance:\nGradual titration of the dosage may be necessary to achieve the desired therapeutic effect while minimizing side effects. Maintenance doses are personalized to each patient’s needs and therapeutic goals.\nMonitoring:\nRegular monitoring of psychiatric symptoms, mood stability, and potential side effects is essential throughout the treatment to ensure the effectiveness and safety of Risperidin 4.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW\nhttps://www.sterisonline.com/product/risperidin-4-133626", "price": 97.5, "discountamount": 29.25, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "life", "food", "brain", "EMAIL", "needs", "safety", "product", "studies", "aspects", "dopamine", "Benefits", "severity", "dementia", "delusions", "frequency", "attention", "treatment", "agitation", "conditions", "medication", "4mg dosage", "aggression", "RISPERIDIN", "information", "mood swings", "Risperidone", "individuals", "Introduction", "sterispharma", "sterisonline", "Key Features", "irritability", "crucial role", "tolerability", "CALL/WHATSAPP", "effectiveness", "schizophrenia", "starting dose", "Administration", "manic episodes", "Initial Dosage", "mood stability", "hallucinations", "bipolar disorder", "overall behavior", "therapeutic goals", "Maintenance doses", "Gradual titration", "patients' quality", "Regular monitoring", "therapeutic effect", "executive function", "Mood Stabilization", "psychotic symptoms", "Dosage adjustments", "Cognitive Function", "social interactions", "emotional stability", "depressive relapses", "serotonin receptors", "psychiatric symptoms", "disorganized thinking", "Behavioral Improvement", "Antipsychotic Efficacy", "potential side effects", "behavioral disturbances", "significant improvements", "autism spectrum disorders", "individual clinical response", "various psychiatric disorders", "overall cognitive performance", "effective second-generation antipsychotic" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1891, "imageuri": "https://productimages.withfloats.com/actual/666be1f8492d7ea0aba14bdd.jpg", "tileimageuri": "https://productimages.withfloats.com/tile/666be1f8492d7ea0aba14bdd.jpg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-14T06:23:49.795Z", "updatedon": "2024-06-26T07:16:04.993Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/risperidin-4-/1891", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "RISPERIDIN 4 ", "category": "NEUROLOGY RANGE", "tags": [ "risperidone 4 mg price", "risperidone side effects", "RISPERIDIN 4", "risperidone 4 mg uses" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "666be1144cb45413344ec2c1", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "RISPERIDIN 2", "description": "RISPERIDIN 2\nRisperidone (2mg)\nIntroduction:\n\nRisperidin 2 encapsulates the therapeutic prowess of Risperidone, a second-generation antipsychotic renowned for its efficacy in managing various psychiatric disorders. With a dosage strength of 2mg, Risperidin 2 offers targeted relief for individuals grappling with conditions such as schizophrenia, bipolar disorder, and certain behavioral disturbances.\nKey Features and Benefits:\n\nAntipsychotic Action:\n\nRisperidin 2 acts primarily as an antagonist of dopamine and serotonin receptors, effectively mitigating psychotic symptoms like delusions, hallucinations, and disorganized thinking.\nMood Stabilization:\n\nBeyond its antipsychotic properties, Risperidin 2 aids in stabilizing mood fluctuations in patients with bipolar disorder, helping to alleviate manic episodes and prevent depressive relapses.\nBehavioral Management:\n\nIn conditions characterized by aggression, agitation, or irritability, such as autism spectrum disorders or dementia-related behavioral disturbances, Risperidin 2 fosters calmer behavior and improves social interactions.\nCognitive Enhancement:\n\nSome studies suggest that Risperidin 2 may contribute to cognitive enhancement in certain individuals, particularly in terms of attention, executive function, and overall cognitive performance.Dosage and Administration:\n\nInitial Dosage:\nThe recommended starting dose of Risperidin 2 is 2mg once daily, administered orally with or without food. Dosage adjustments may be made based on clinical response and tolerability.\nTitration and Maintenance:\nHealthcare providers may titrate Risperidin 2 gradually to achieve optimal symptom control while minimizing adverse effects. Maintenance doses are tailored to individual patient needs and treatment goals.\nContinued Monitoring:\nRegular monitoring of psychiatric symptoms, mood stability, behavioral changes, and potential side effects is crucial throughout Risperidin 2 therapy to ensure therapeutic efficacy and patient well-being.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW\nhttps://www.sterisonline.com/product/risperidin-2-133625", "price": 47.9, "discountamount": 14.37, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "2mg", "food", "EMAIL", "terms", "studies", "product", "Benefits", "patients", "dopamine", "attention", "delusions", "agitation", "Titration", "antagonist", "conditions", "aggression", "individuals", "Risperidone", "information", "Introduction", "irritability", "sterisonline", "sterispharma", "tolerability", "Key Features", "CALL/WHATSAPP", "starting dose", "schizophrenia", "Initial Dosage", "mood stability", "hallucinations", "manic episodes", "Administration", "treatment goals", "adverse effects", "dosage strength", "targeted relief", "calmer behavior", "bipolar disorder", "clinical response", "mood fluctuations", "Maintenance doses", "Regular monitoring", "Dosage adjustments", "patient well-being", "executive function", "behavioral changes", "Mood Stabilization", "psychotic symptoms", "serotonin receptors", "social interactions", "depressive relapses", "therapeutic prowess", "psychiatric symptoms", "Risperidin 2 therapy", "therapeutic efficacy", "Healthcare providers", "Continued Monitoring", "Antipsychotic Action", "disorganized thinking", "Behavioral Management", "Cognitive Enhancement", "potential side effects", "optimal symptom control", "individual patient needs", "antipsychotic properties", "autism spectrum disorders", "various psychiatric disorders", "overall cognitive performance", "second-generation antipsychotic", "dementia-related behavioral disturbances" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1890, "imageuri": "https://productimages.withfloats.com/actual/666be11a5e294343790f23a2.jpg", "tileimageuri": "https://productimages.withfloats.com/tile/666be11a5e294343790f23a2.jpg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-14T06:20:04.792Z", "updatedon": "2024-06-26T07:16:51.227Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/risperidin-2/1890", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "RISPERIDIN 2", "category": "NEUROLOGY RANGE", "tags": [ "risperidone 2 mg uses", "risperidone 2mg", "risperidone 2 mg side effects", "risperidone side effects long-term" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "666aeaa9ca84cd189c25cce6", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "RISPERIDIN 1 ", "description": "RISPERIDIN 1 \nRisperidone (1mg)\nIntroduction:\n\nRisperidin 1 encapsulates the therapeutic prowess of Risperidone, a second-generation antipsychotic renowned for its efficacy in managing various psychiatric disorders. With a dosage strength of 1mg, Risperidin 1 offers targeted relief for individuals grappling with conditions such as schizophrenia, bipolar disorder, and certain behavioral disturbances.\nKey Features and Benefits:\n\nAntipsychotic Action:\n\nRisperidin 1 exerts its primary action as an antagonist of dopamine and serotonin receptors, effectively mitigating psychotic symptoms like delusions, hallucinations, and disorganized thinking.\nMood Stabilization:\n\nBeyond its antipsychotic properties, Risperidin 1 aids in stabilizing mood fluctuations in patients with bipolar disorder, helping to alleviate manic episodes and prevent depressive relapses.\nBehavioral Management:\n\nIn conditions characterized by aggression, agitation, or irritability, such as autism spectrum disorders or dementia-related behavioral disturbances, Risperidin 1 fosters calmer behavior and improves social interactions.\nCognitive Enhancement:\n\nSome studies suggest that Risperidin 1 may contribute to cognitive enhancement in certain individuals, particularly in terms of attention, executive function, and overall cognitive performance.\nDosage and Administration:\n\nInitial Dosage:\nThe recommended starting dose of Risperidin 1 is 1mg once daily, administered orally with or without food. Dosage adjustments may be made based on clinical response and tolerability.\nTitration and Maintenance:\nHealthcare providers may titrate Risperidin 1 gradually to achieve optimal symptom control while minimizing adverse effects. Maintenance doses are tailored to individual patient needs and treatment goals.\nContinued Monitoring:\nRegular monitoring of psychiatric symptoms, mood stability, behavioral changes, and potential side effects is crucial throughout Risperidin 1 therapy to ensure therapeutic efficacy and patient well-being.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW\nhttps://www.sterisonline.com/product/risperidin-1-133624", "price": 29.8, "discountamount": 8.94, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "1mg", "food", "EMAIL", "terms", "product", "studies", "Benefits", "patients", "dopamine", "agitation", "attention", "delusions", "Titration", "antagonist", "conditions", "aggression", "individuals", "Risperidone", "information", "sterisonline", "irritability", "tolerability", "sterispharma", "Introduction", "Key Features", "starting dose", "CALL/WHATSAPP", "schizophrenia", "mood stability", "Administration", "manic episodes", "Initial Dosage", "primary action", "hallucinations", "calmer behavior", "treatment goals", "adverse effects", "targeted relief", "dosage strength", "bipolar disorder", "Maintenance doses", "clinical response", "mood fluctuations", "Regular monitoring", "executive function", "Mood Stabilization", "psychotic symptoms", "patient well-being", "Dosage adjustments", "behavioral changes", "social interactions", "depressive relapses", "serotonin receptors", "therapeutic prowess", "Continued Monitoring", "therapeutic efficacy", "Risperidin 1 therapy", "Antipsychotic Action", "psychiatric symptoms", "Healthcare providers", "Behavioral Management", "Cognitive Enhancement", "disorganized thinking", "potential side effects", "optimal symptom control", "antipsychotic properties", "individual patient needs", "autism spectrum disorders", "overall cognitive performance", "various psychiatric disorders", "second-generation antipsychotic", "dementia-related behavioral disturbances" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1889, "imageuri": "https://productimages.withfloats.com/actual/666aeaacae2cbfae74d27277.jpg", "tileimageuri": "https://productimages.withfloats.com/tile/666aeaacae2cbfae74d27277.jpg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-13T12:48:41.435Z", "updatedon": "2024-06-26T07:17:54.413Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/risperidin-1-/1889", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "RISPERIDIN 1 ", "category": "NEUROLOGY RANGE", "tags": [ "risperidone side effects long-term", "risperidone 1mg", "risperidone 1mg uses in hindi", "risperidone 1 mg side effects" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "68d51d9a26579f4bc195771a", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Glimepiride IP1 mg, Voglibose IP 0.2 MG & Metformin Hydrochloride IP 500 mg ", "description": "GLIMITERIS MV1 0.2 is an advanced fixed-dose combination (FDC) medication designed for adults with Type 2 Diabetes Mellitus (T2DM) who require more than lifestyle modifications or single/dual therapy to maintain optimal blood sugar levels. This innovative formulation brings together the power of three well-established antidiabetic agents—Glimepiride (1 mg), Voglibose (0.2 mg), and Metformin Hydrochloride SR (500 mg)—to provide comprehensive glycemic control.\n\nIt is particularly effective for patients struggling with postprandial hyperglycemia, fasting glucose regulation, and HbA1c reduction, making it a preferred choice in cases of poorly controlled diabetes.\n\n \n\nMechanism of Action\nThe therapeutic benefit of GLIMITERIS MV1 0.2 comes from the unique synergy of its three components, each targeting different aspects of glucose metabolism:\n\n1. Glimepiride (1 mg) – Sulfonylurea\nStimulates insulin secretion by activating pancreatic beta cells.\n\nProvides a long-lasting effect with comparatively lower hypoglycemia risk than older sulfonylureas.\n\nHelps reduce both fasting and postprandial glucose levels.\n\n2. Voglibose (0.2 mg) – Alpha-Glucosidase Inhibitor\nDelays the breakdown and absorption of carbohydrates in the intestine.\n\nMinimizes post-meal glucose spikes (PPBG).\n\nActs locally in the gut and has minimal systemic absorption, which reduces systemic side effects.\n\n3. Metformin Hydrochloride SR (500 mg) – Biguanide\nDecreases hepatic glucose production (gluconeogenesis).\n\nImproves peripheral insulin sensitivity, enhancing glucose uptake in muscles.\n\nDoes not cause hypoglycemia on its own.\n\nThe sustained-release (SR) formulation ensures extended control and reduces gastrointestinal side effects.\n\n \n\nIndications\nGLIMITERIS MV1 0.2 is indicated for:\n\nAdults with Type 2 Diabetes Mellitus.\n\nPatients inadequately controlled with monotherapy or dual therapy.\n\nManagement of fasting and postprandial hyperglycemia.\n\nLong-term HbA1c reduction as part of a comprehensive diabetes care plan.\n\n \n\nKey Benefits\n✅ Comprehensive Blood Sugar Control – Acts on fasting, post-meal, and long-term HbA1c levels.\n✅ Postprandial Spike Management – Voglibose effectively controls carbohydrate-induced sugar surges.\n✅ Reduced Pill Burden – Combines three medicines into a single tablet.\n✅ Lower Hypoglycemia Risk – Metformin and Voglibose balance out Glimepiride’s insulin-secreting effect.\n✅ Weight Management Support – Metformin may promote modest weight loss or prevent weight gain.\n✅ Improved Tolerability – SR formulation of Metformin enhances gastrointestinal comfort.\n\n \n\nDosage and Administration\nRecommended dose: One tablet once or twice daily with meals, or as directed by the physician.\n\nAdministration tips:\n\nTake with the first bite of a main meal to maximize Voglibose’s effect.\n\nSwallow whole with water; do not crush or chew the SR tablet.\n\nDose adjustments: Based on blood sugar monitoring, clinical response, and renal/hepatic function.\n\n \n\nContraindications\nGLIMITERIS MV1 0.2 is not suitable for patients with:\n\nType 1 diabetes or diabetic ketoacidosis.\n\nSevere renal impairment (eGFR <30 mL/min/1.73 m²).\n\nHepatic dysfunction.\n\nSevere gastrointestinal diseases.\n\nHistory of lactic acidosis.\n\nHypersensitivity to Glimepiride, Voglibose, or Metformin.\n\nPregnancy and lactation (unless strictly advised by a physician).\n\n \n\nWarnings and Precautions\nHypoglycemia: Risk is higher when combined with other antidiabetics or with missed meals.\n\nLactic Acidosis: A rare but life-threatening effect of Metformin—renal function monitoring is essential.\n\nGI Side Effects: Voglibose and Metformin may cause bloating, flatulence, or diarrhea (usually temporary).\n\nVitamin B12 Monitoring: Long-term Metformin use may reduce B12 absorption.\n\nLiver and Kidney Function: Regular monitoring is recommended for safe long-term use.\n\n \n\nAdverse Effects\nCommon:\nGlimepiride: Mild hypoglycemia, dizziness, slight weight gain.\n\nVoglibose: Gas, abdominal discomfort, mild diarrhea.\n\nMetformin SR: Nausea, bloating, metallic taste, loose stools.\n\nRare but Serious:\nLactic acidosis (from Metformin).\n\nSevere hypoglycemia (especially if meals are skipped).\n\nAllergic reactions such as rash, itching, or swelling.\n\nElevated liver enzymes.\n\nSeek medical attention if symptoms such as rapid breathing, confusion, severe fatigue, or muscle pain occur.\n\n \n\nDrug Interactions\nIncreased hypoglycemia risk: With insulin, beta-blockers, and sulfonylureas.\n\nReduced Metformin efficacy: With corticosteroids, estrogens, and diuretics.\n\nLactic acidosis risk: Higher with alcohol or iodinated contrast agents. ", "price": 263.0, "discountamount": 80.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2182, "imageuri": "https://productimages.withfloats.com/actual/68d51d9cdf1a4ca2c252370a.png", "tileimageuri": "https://productimages.withfloats.com/tile/68d51d9cdf1a4ca2c252370a.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-09-25T10:46:50.098Z", "updatedon": "2025-09-25T10:46:50.098Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/glimepiride-ip1-mg-voglibose-ip-0-2-mg-metformin-hydrochloride-ip-500-mg-/2182", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "GLIMITERIS MV1 0.2", "category": "", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "68c29ba02244c906e7790e2b", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "TELAVINCE 300", "description": "TELAVINCE 300 is a high-quality antiviral medication containing Tenofovir Disoproxil Fumarate 300 mg, specifically formulated for the effective management of HIV-1 infection and chronic Hepatitis B in adults and adolescents. Manufactured under strict pharmaceutical standards, TELAVINCE 300 offers consistent, potent, and clinically proven antiviral action, helping to suppress viral replication and improve immune function.\n\nTenofovir Disoproxil Fumarate is a nucleotide reverse transcriptase inhibitor (NtRTI). It works by interfering with the enzyme reverse transcriptase, which is essential for viral replication in HIV and Hepatitis B viruses. By inhibiting this enzyme, TELAVINCE 300 reduces the amount of virus in the body, helping to prevent further immune system damage and liver complications.\n\n \nKey Indications:\n \n\nTELAVINCE 300 is indicated for:\n\nHIV-1 Infection: In combination with other antiretroviral agents for the treatment of HIV-1 in adults and adolescents (aged 12 years and older, weighing at least 35 kg).\n\nChronic Hepatitis B: For the treatment of chronic hepatitis B virus infection in adults and adolescents with compensated liver disease and evidence of active viral replication.\n\n \nMechanism of Action:\n \nTenofovir Disoproxil Fumarate is a prodrug of tenofovir, which, once absorbed and metabolized in the body, is converted into tenofovir diphosphate, the active form. Tenofovir diphosphate acts as a competitive inhibitor of reverse transcriptase, incorporating itself into the viral DNA chain and causing premature chain termination. This process disrupts the life cycle of the virus, significantly reducing its ability to multiply and spread.\n\n \nDosage and Administration:\n \n\nRecommended Dose for Adults and Adolescents (≥12 years, ≥35 kg): One tablet (300 mg) once daily, preferably with food.\n\nFor HIV Treatment: Administer in combination with other antiretroviral medications as per the treatment regimen.\n\nFor Chronic Hepatitis B: Monotherapy or as part of combination therapy, depending on patient condition and physician's assessment.\n\nDosage adjustments may be required in patients with renal impairment. Close monitoring is recommended for patients with existing kidney disease.\n\n \nKey Benefits of TELAVINCE 300:\n \n\nPotent Antiviral Action: Rapid and sustained suppression of HIV and HBV replication.\nOnce-Daily Dosing: Improves patient compliance and treatment adherence.\n\nBacked by Clinical Research: Proven efficacy in managing viral load and improving immune markers (CD4 count).\n\nTrusted Quality: Manufactured under GMP-certified facilities with stringent quality control processes.\n\nPart of First-Line Therapy: Recommended in various national and international treatment guidelines for HIV and Hepatitis B.\n\n \nSafety and Precautions:\n \n\nRenal Monitoring: Tenofovir may affect kidney function. Routine renal function tests are recommended before and during treatment.\n\nBone Mineral Density: Long-term use may reduce bone mineral density. Consider monitoring in patients at risk of osteopenia or osteoporosis.\n\nHepatic Flare: Discontinuation of therapy in hepatitis B patients may result in severe acute exacerbations. Liver function should be closely monitored post-treatment.\n\nLactic Acidosis and Hepatomegaly: Rare but serious side effects. Patients presenting symptoms such as abdominal pain, fatigue, or difficulty breathing should seek immediate medical attention.\n\n \n\nPossible Side Effects:\n \n\nMost patients tolerate TELAVINCE 300 well. However, some may experience:\n\nNausea\n\nDiarrhea\n\nHeadache\n\nFatigue\n\nRash\n\nDizziness\n\nDecreased bone mineral density\n\nRenal impairment (in rare cases)\n\nIf any side effects persist or worsen, consult a healthcare professional immediately.\n\n \nStorage Instructions:\n \n\nStore in a cool, dry place below 30°C.\n\nProtect from light and moisture.\n\nKeep out of reach of children.\n\n \n\nWhy Choose TELAVINCE 300?\n \n\nTELAVINCE 300 offers a dependable, clinically validated solution for the long-term management of HIV and Hepatitis B. With its once-daily dosing and proven effectiveness, TELAVINCE 300 is an ideal choice for patients and healthcare providers looking for quality, safety, and therapeutic reliability. It is manufactured by a trusted name in healthcare, ensuring every tablet meets global pharmaceutical standards.\n\n \nDisclaimer:\n \n\nThis product description is for informational purposes only and is not a substitute for professional medical advice. Always consult your doctor or healthcare provider before starting any medication.", "price": 1480.0, "discountamount": 444.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2179, "imageuri": "https://productimages.withfloats.com/actual/68c29ba3794abb27ab248d73.png", "tileimageuri": "https://productimages.withfloats.com/tile/68c29ba3794abb27ab248d73.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-09-11T09:51:28.508Z", "updatedon": "2025-09-11T09:51:28.508Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/telavince-300/2179", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Tenofovir Disoproxil Fumarate Tablets ip 300 mg", "category": "GENERAL RANGE", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "68beb194933ec7924333073c", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "PYRITIGMIN RIVA 1.5", "description": "Rivastigmine 1.5 mg capsule, marketed as PYRITIGMIN RIVA 1.5, is a prescription medication primarily used for the treatment of mild to moderate dementia associated with Alzheimer’s disease and Parkinson’s disease. It belongs to a class of drugs known as cholinesterase inhibitors, which work by increasing the levels of acetylcholine, a chemical messenger in the brain, to improve cognitive function, memory, and daily activities.\n\n \n\nComposition of Rivastigmine 1.5 mg Capsule\n \n\nActive Ingredient: Rivastigmine 1.5 mg\n\nBrand Name: PYRITIGMIN RIVA 1.5\n\nForm: Capsule\n\nCategory: Cholinesterase inhibitor\n\nManufacturer: Steris Healthcare\n\nEach capsule contains 1.5 mg of Rivastigmine, along with inactive excipients that help in capsule stability and absorption.\n\n \nWhat is Rivastigmine 1.5 mg?\n \n\nRivastigmine 1.5 mg is a central nervous system (CNS) acting drug used to treat cognitive decline in patients with Alzheimer’s and Parkinson’s disease dementia.\n\nIt inhibits the enzyme acetylcholinesterase, which breaks down acetylcholine in the brain.\n\nBy increasing acetylcholine levels, it enhances communication between nerve cells, improving memory, attention, and problem-solving skills.\n\nPYRITIGMIN RIVA 1.5 is suitable for patients who require a low starting dose, helping to minimize side effects during treatment initiation.\n\n \nUses of Rivastigmine 1.5 mg Capsules\n \n\nTreatment of Mild to Moderate Alzheimer’s Disease\n\nImproves cognitive function, memory, and daily activity performance.\n\nManagement of Parkinson’s Disease Dementia\n\nHelps in improving memory, attention, and behavioral symptoms.\n\nSupportive Therapy for Cognitive Decline\n\nSlows the progression of dementia-related symptoms.\n\n \nDosage and Administration\n \n\nStarting Dose: 1.5 mg capsule twice daily (morning and evening) or as prescribed by a doctor.\nCapsules should be swallowed whole with water, preferably after meals to reduce gastrointestinal side effects.\n\nDose may be gradually increased based on tolerance and clinical response.\n\nRegular monitoring of weight, appetite, and cognitive function is recommended during therapy.\n\n \nBenefits of Rivastigmine 1.5 mg Capsules\n \n\nImproves memory and cognitive function\n\nEnhances daily living activities in dementia patients\n\nReduces behavioral and psychiatric symptoms associated with Alzheimer’s and Parkinson’s dementia\n\nProvides gradual symptom management with minimal side effects when initiated at low doses\n\nPYRITIGMIN RIVA 1.5 is patient-friendly due to its low starting dose\n\n \nSide Effects of Rivastigmine 1.5 mg Capsules\n \n\nWhile generally well-tolerated, some patients may experience mild to moderate side effects:\n\nNausea and vomiting\n\nLoss of appetite or weight loss\n\nDiarrhea\n\nDizziness or headache\n\nFatigue\n\nTremors\n\nSerious side effects (rare) include:\n\nSevere vomiting or dehydration\n\nAllergic reactions (rash, swelling, difficulty breathing)\n\nHeart rhythm changes (bradycardia)\n\nPatients should inform their doctor if any severe or persistent side effects occur.\n\n \nPrecautions Before Using Rivastigmine 1.5 mg\n \n\nInform your doctor if you have heart disease, liver problems, kidney disease, or stomach ulcers.\n\nUse with caution in patients prone to fainting or low blood pressure.\n\nNot recommended during pregnancy or breastfeeding unless prescribed by a healthcare provider.\n\nAvoid sudden discontinuation of medication to prevent worsening of cognitive symptoms.\n\nMonitor for gastrointestinal issues and maintain hydration during therapy.\n\n \nDrug Interactions\n \n\nRivastigmine may interact with certain medications:\n\nCholinergic drugs (e.g., pilocarpine, bethanechol) – may increase cholinergic effects\n\nAnticholinergic drugs (e.g., atropine, scopolamine) – may reduce Rivastigmine’s effectiveness\n\nBeta-blockers or antiarrhythmics – may increase risk of slow heart rate\n\nNSAIDs or anticoagulants – monitor for gastrointestinal bleeding\n\nAlways inform your healthcare provider about all medications, supplements, and herbal products you are taking.\n\n \nConclusion\n \n\nRivastigmine 1.5 mg Capsules (PYRITIGMIN RIVA 1.5) are an effective treatment for cognitive decline associated with Alzheimer’s and Parkinson’s dementia.Always use Rivastigmine 1.5 mg under medical supervision, and follow prescribed dosage and lifestyle recommendations to achieve optimal cognitive support.", "price": 192.0, "discountamount": 58.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2176, "imageuri": "https://productimages.withfloats.com/actual/68beb197484e8a57b992d471.png", "tileimageuri": "https://productimages.withfloats.com/tile/68beb197484e8a57b992d471.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-09-08T10:36:04.37Z", "updatedon": "2025-09-08T10:36:04.37Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/pyritigmin-riva-1-5/2176", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "rivastigmine 1.5 mg capsule", "category": "", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "68bc22e83c3803d861d696a9", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "CEPHODOXIAA 200", "description": "CEPHODOXIAA 200 is a broad-spectrum oral antibiotic from Steris Healthcare Pvt. Ltd., containing Cefpodoxime Proxetil 200 mg. It belongs to the third-generation cephalosporin class, designed to combat a wide range of bacterial infections effectively. With its high bioavailability, safety profile, and proven efficacy, it is trusted in clinical practice for managing both respiratory and urinary tract infections.\n\nUsage and Benefits\nCEPHODOXIAA 200 is prescribed for the treatment of bacterial infections caused by susceptible microorganisms, including:\n\nRespiratory tract infections (bronchitis, pneumonia, sinusitis, pharyngitis, tonsillitis)\n\nUrinary tract infections (cystitis, pyelonephritis)\n\nEar infections (otitis media)\n\nSkin and soft tissue infections\n\nCertain sexually transmitted infections (like gonorrhea)\n\nCommunity-acquired infections where cephalosporins are indicated\n\nBenefits:\n\nBroad-spectrum antibacterial activity against gram-positive and gram-negative organisms\n\nHigh tolerability and oral bioavailability\n\nConvenient twice-daily dosing\n\nEffective alternative when resistance to other antibiotics is suspected\n\nDosage and Administration\nAdults: Typical dose is 200 mg every 12 hours, depending on the severity of the infection.\n\nChildren: Dose is weight-adjusted, usually prescribed in suspension form.\n\nDuration: Treatment typically lasts 5–14 days depending on the infection type and clinical response.\n\nAdministration Tips:\n\nTake with food to enhance absorption.\n\nComplete the full course even if symptoms improve early.\n\nDo not double the dose if a dose is missed—take it as soon as remembered unless it is nearly time for the next dose.\n\nSide Effects\nLike all medicines, CEPHODOXIAA 200 may cause mild to moderate side effects. Common ones include:\n\nGastrointestinal upset (nausea, diarrhea, abdominal pain)\n\nHeadache or dizziness\n\nSkin rash or itching\n\nRare but serious side effects:\n\nSevere allergic reactions (swelling, difficulty breathing)\n\nPseudomembranous colitis (persistent diarrhea)\n\nLiver enzyme elevations\n\nDrug Interactions\nAntacids & H2 blockers: May reduce absorption of Cefpodoxime. Take at least 2–3 hours apart.\n\nBlood thinners (e.g., warfarin): May increase risk of bleeding.\n\nOther antibiotics: Avoid concurrent use unless directed by a doctor to prevent resistance.\n\nAlways inform your physician of all medications and supplements you are taking before starting therapy.\n\nConclusion\nCEPHODOXIAA 200 (Cefpodoxime Proxetil 200 mg) from Steris Healthcare Pvt. Ltd. is a reliable, broad-spectrum antibiotic used in the management of common bacterial infections. With its excellent safety profile, ease of oral administration, and clinical efficacy, it remains a preferred choice for doctors worldwide. Patients should adhere strictly to prescribed dosage and complete the treatment course to ensure optimal results and prevent antibiotic resistance.", "price": 185.0, "discountamount": 54.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2173, "imageuri": "https://productimages.withfloats.com/actual/68bc22f9fc1a4c6e66f328c5.png", "tileimageuri": "https://productimages.withfloats.com/tile/68bc22f9fc1a4c6e66f328c5.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-09-06T12:02:48.098Z", "updatedon": "2025-09-08T10:03:20.923Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/cephodoxiaa-200/2173", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Cefpodoxime Proxetil Tablets IP 200 mg", "category": "GENERAL RANGE", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "68b6d6c76f14ecfa6add5d56", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "SACUSMART 200", "description": "Description: \nSACUSMART 200 is a combination medicine containing Sacubitril (97 mg) and Valsartan (103 mg), specifically designed to manage chronic heart failure with reduced ejection fraction (HFrEF). This dual-acting therapy is classified as an angiotensin receptor neprilysin inhibitor (ARNI) and is widely prescribed to reduce the risk of cardiovascular death and hospitalization in patients with heart failure.\n\nHeart failure is a progressive condition where the heart cannot pump blood efficiently to meet the body’s needs. SACUSMART 200 improves the efficiency of the heart by relaxing blood vessels, reducing fluid retention, and lowering strain on the heart, helping patients live a better and longer life.\n\n \nWhat is SACUSMART 200?\n \n\nSACUSMART 200 is a highly effective heart failure medication that combines two active components:\n\nSacubitril (97 mg) – a neprilysin inhibitor that increases levels of natriuretic peptides, leading to vasodilation, sodium excretion, and reduced stress on the heart.\n\nValsartan (103 mg) – an angiotensin II receptor blocker (ARB) that relaxes blood vessels, lowers blood pressure, and prevents harmful effects of angiotensin II.\n\nTogether, these mechanisms make SACUSMART 200 a superior alternative to traditional ACE inhibitors or ARBs alone in treating chronic heart failure.\n\n \nUses of SACUSMART 200\n \n\nSACUSMART 200 is prescribed for:\n\nChronic heart failure with reduced ejection fraction (HFrEF)\n\nReducing risk of hospitalization due to worsening heart failure\n\nImproving survival rates in patients with heart failure\n\nEnhancing exercise tolerance and quality of life in long-term heart failure management\n\n \nBenefits of SACUSMART 200\n \n\nDual action with neprilysin inhibition + ARB effect for comprehensive heart protection\n\nProven to reduce mortality and hospitalization risk in heart failure patients\n\nImproves symptoms such as breathlessness, fatigue, and swelling\n\nHelps patients regain better physical stamina and daily activity levels\n\nLong-term use significantly contributes to improved quality of life\n\n \nPossible Side Effects of SACUSMART 200\n \n\nWhile SACUSMART 200 is effective and generally well tolerated, some patients may experience:\n\nLow blood pressure (hypotension)\n\nIncreased blood potassium levels (hyperkalemia)\n\nDizziness or light-headedness\n\nKidney function changes\n\nCough\n\nRarely, serious allergic reactions or angioedema (swelling of face, lips, or throat)\n\nImmediate medical attention is required if severe swelling, difficulty breathing, or fainting occurs.\n\n \nPrecautions Before Using SACUSMART 200\n \n\nDo not use if you are allergic to sacubitril, valsartan, or other ARBs\n\nAvoid if you have taken an ACE inhibitor within the last 36 hours due to the risk of angioedema\n\nNot recommended for patients with a history of hereditary angioedema\n\nCaution in patients with severe kidney or liver disease\n\nPregnant and breastfeeding women should avoid this medicine due to harmful effects on the baby\n\nAlways monitor blood pressure, kidney function, and potassium levels while on this treatment\n\n \nDrug Interactions\n \n\nSACUSMART 200 may interact with:\n\nACE inhibitors – should not be combined, risk of angioedema\n\nPotassium supplements or potassium-sparing diuretics – risk of high potassium\n\nNSAIDs (e.g., ibuprofen, naproxen) – may reduce kidney function\n\nLithium – risk of lithium toxicity\n\nDiuretics – may increase the risk of low blood pressure\n\nAlways inform your doctor about all medicines, supplements, or herbal products you are taking before starting SACUSMART 200.\n\n \nConclusion\n \n\nSACUSMART 200 (Sacubitril 97 mg & Valsartan 103 mg) is a breakthrough treatment in managing chronic heart failure with reduced ejection fraction (HFrEF). By combining neprilysin inhibition and angiotensin receptor blockade, it not only reduces symptoms but also significantly lowers the risk of hospitalization and death, improving both longevity and quality of life.\n\nFor patients living with heart failure, SACUSMART 200 offers a scientifically proven and clinically superior solution to regain control over their health and live a more fulfilling life.", "price": 750.0, "discountamount": 225.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2170, "imageuri": "https://productimages.withfloats.com/actual/68b6d6c9c4087f14f55d7d23.png", "tileimageuri": "https://productimages.withfloats.com/tile/68b6d6c9c4087f14f55d7d23.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-09-02T11:36:39.17Z", "updatedon": "2025-09-02T11:36:39.17Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/sacusmart-200/2170", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Sacubitril and Valsartan Tablets (97 mg + 103 mg)", "category": "CARDIOLOGYRANGE", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "68b02393f5434d48fca8b8ca", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "TRELAQWK 50", "description": "TRELAQWK 50 is a modern oral antidiabetic tablet containing Trelagliptin 50 mg, specially developed for adults with type 2 diabetes mellitus. This once-weekly medication helps regulate blood sugar effectively, offering both convenience and strong clinical outcomes. With its advanced formulation, TRELAQWK 50 supports better glycemic control, making it easier for patients to lead a balanced and healthier lifestyle.\nManufactured under strict quality standards, TRELAQWK 50 ensures patient compliance, long-term safety, and efficacy in diabetes management.\nKey Ingredient\nTrelagliptin (50 mg):\nA unique, long-acting DPP-4 (dipeptidyl peptidase-4) inhibitor that allows weekly dosing, ensuring higher treatment adherence while maintaining effective control over blood glucose levels.\nKey Benefits of TRELAQWK 50\nProvides consistent blood sugar management with just one tablet per week\nEnhances insulin secretion while lowering glucagon levels in a glucose-dependent manner\nHelps reduce both fasting and postprandial blood glucose\nConvenient choice for patients with busy schedules who struggle with daily tablets\nLow risk of hypoglycemia when used as monotherapy\nSupports long-term improvement in HbA1c levels\nMechanism of Action – How TRELAQWK 50 Works\nTRELAQWK 50 works by blocking the DPP-4 enzyme, which normally degrades incretin hormones such as GLP-1 and GIP. These incretins are vital for maintaining blood sugar balance. By prolonging incretin activity, trelagliptin:\nStimulates insulin secretion from the pancreas\nReduces glucagon release from alpha cells\nHelps lower blood sugar, particularly after meals\nThis mechanism provides both effective glycemic control and improved patient compliance.\nDirections for Use\nTake one tablet of TRELAQWK 50 once a week, on the same day each week\nCan be taken with or without food\nSwallow whole with a glass of water\nFollow your doctor’s advice for dosage adjustment\nDo not double the dose if missed; consult your healthcare provider\nPossible Side Effects\nTRELAQWK 50 is usually well-tolerated. However, some patients may experience:\nMild headache\nNasopharyngitis (cold-like symptoms)\nDiarrhea\nStomach discomfort or indigestion\nRare allergic reactions (rash, itching)\nIf any unusual or persistent side effects occur, seek medical advice promptly.", "price": 375.0, "discountamount": 112.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2165, "imageuri": "https://productimages.withfloats.com/actual/68b023971624ba892ffd8c69.png", "tileimageuri": "https://productimages.withfloats.com/tile/68b023971624ba892ffd8c69.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-08-28T09:38:27.036Z", "updatedon": "2025-08-28T09:38:27.036Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/trelaqwk-50/2165", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "trelagliptin 50 mg", "category": "DIABETIC RANGE", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false } ], "hasmoreitems": false, "isapirequest": false, "totalresults": 27, "query": null, "floatingpoint": null }